Abstract
The presence of cholecystokinin (CCK) in extracts of intestine was first described by Ivy and Oldberg (1928), but it was not until 1975 that its occurrence in vertebrate brain was detected (Vanderhaeghen et al., 1975; Dockray, 1976). CCK occurs in brain mainly as the sulphated octapeptide and in the last few years numerous papers have been published on the distribution in the CNS of CCK-containing neurones, although their functional significance remains obscure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Chang, R., Lotti, V., Martin, G. and Chen, T.B. (1983). Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxyobpamine or ventral tegmental lesions. Life Sci., 32, 871–878.
Chang, R.L. and Lotti, V.J. (1986). Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist. Proc. Natl. Acad. Sci., USA 83, 4923–4926.
Crawley, J.N. (1985). In: Annals of the New York Academy of Science, Vol 448, 283–292 NeuronalCholecvstokinin (eds J.J. Vanderhaeghen and J.N. Crawley) The New York Academy of Sciences, New York.
Day, N.C., Hall, M.D., Clark, C.R. and Hughes, J. (1986). High concentrations of cholecystokinin receptor binding sites in the ventromedial hypothalamic nucleus. Neuropeptides 8, 1–18.
Dockray, G.J. (1976). Ininunochemical evidence of cholecystokinin-like peptides in brain. Nature (London), 264, 568–570.
Evans, B.E., Bock, M.G., Rittie, K.E., Dipardo, R.M., Whitter, W.L., Veber, D.F., Anderson, P.S. and Freidinger, R. (1986). Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc. Natl. Acad. Sci. U.S.A., 83, 4918–4922.
Fallon, J.H., Wang, C., Kim, Y., Canepa, N., Loughlin, S. and Seroogy, K. (1983). Dopamine and cholecystokinin containing neurones of the crossed mesostriatal projection. Neuroscience Letters, 40, 233–238.
Hill, D.R., Cambell, N.J., Shaw, T.M. and Woodruff, G.N. (1987a). Autoradiographic localisation and biochemical characterisation of peripheral type CCK receptors in the rat CNS using highly selective, non-peptide CCK antagonists. J. Neurosci., 7, 2967–2976.
Hill, D.R., Shaw, T.M. and Woodruff, G.N. (1987b). Species difference in the localization of “peripheral” type CCK receptors in rodent brain. Neurosci. Letters 79 286–289.
Hokfelt, T., Rehfeld, J.F., Skirboll, L., Ivemark, B., Goldstein, M. and Markey, K. (1980a). Evidence for co-existence of dopamine and cholecystokinin in mesolimbic neurones. Nature (London), 285, 476–478.
Hokfelt, T., Skirboll, L., Rehfeld, J.F., Goldstein, M., Markey, K. and Dann, O. (1980b). A subpopulation of mes-encephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing. Neuroscience, 5, 2093–2124.
Innis, R.B. and Snyder, S.H. (1980). Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci., USA, 77, 6917–6921.
Innis, R.B., Correa, F.M.A., Uhl, G.R., Screider, B. and Snyder, S.H. (1979). Cholecystokinin octapeptide immuno-reactivity histochemical localization in rat brain. Proc. Natl. Acad. Sci. USA, 76, 521–535.
Ivy, A.C. and Oldberg, E. (1928). A hormone mechanism for gall bladder contraction and evacuation. Am. J. Physiol., 86, 599–613.
Kemp, J.A., Marshall, G.A. and Woodruff, G.N. (1986). Quantative evaluation of the potencies of GABA-receptor agonists and antagonists using the rat hippocampal slice preparation. Br. J. Pharmac., 87, 677–684.
Moran, T.H., Robinson, P., Goldrich, M.S. and McHugh, P. (1986). Two brain cholecystolkinin receptors: implications for behavioural actions. Brain Res., 362, 175–179.
Saito, A., Sankaran, H., Goldrine, I.D. and Williams, J.A. (1980). Cholecystokinin receptors in the brain: characterization and distribution. Science, 208 1155–1156.
Skirboll, L.R., Grace, A.A., Hommer, D.W., Rehfeld, J., Goldstein, M., Hokfelt, T. and Bunney, B.S. (1981). Peptide-monoamine coexistence: studies on the actions of cholecystokinin-like peptides on the electrical activity of midbrain dopamine neurones. Neuroscience, 6, 2111–2124.
Vanderhaeghen, J.J., Signeau, J.C. and Gepts, W. (1975). New peptide in the vertebrate CNS reacting with gastrin antibodies. Nature (London), 257, 604–605.
Wang, R.Y. and Hu, X.T. (1986). Does cholecystokinin potentiate dopamine action in the nucleus accumbens? Brain Res., 380, 363–367.
White, F.J. and Wang, R.Y. (1984). Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons. Brain. Res., 300, 161–166.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1988 G.N. Woodruff, D.R. Hill, J.A. Kemp, T.M. Shaw, A.R. Crossman and W.C. Graham
About this chapter
Cite this chapter
Woodruff, G.N., Hill, D.R., Kemp, J.A., Shaw, T.M., Crossman, A.R., Graham, W.C. (1988). CCK Receptors and Brain Dopaminergic Systems. In: Beart, P.M., Woodruff, G.N., Jackson, D.M. (eds) Pharmacology and Functional Regulation of Dopaminergic Neurons. Satellite Symposia of the IUPHAR 10th International Congress of Pharmacology. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-10047-7_47
Download citation
DOI: https://doi.org/10.1007/978-1-349-10047-7_47
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-10049-1
Online ISBN: 978-1-349-10047-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)